We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
351
Constellation Brands
STZ
$21.2B
$11M 0.05%
128,978
-52,700
-29% -$4.19M
BSAC icon
352
Banco Santander Chile
BSAC
$16.4B
$10.9M 0.05%
465,775
+414,905
+816% +$8.99M
FRX
353
DELISTED
FOREST LABORATORIES INC
FRX
$10.9M 0.05%
117,981
-1,802
-2% -$145K
ETN icon
354
Eaton
ETN
$152B
$10.7M 0.05%
143,023
+38,023
+36% +$2.8M
VR
355
DELISTED
Validus Hold Ltd
VR
$10.7M 0.05%
284,678
-158,783
-36% -$5.88M
GEVA
356
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$10.6M 0.05%
128,061
+4,230
+3% +$391K
TRMB icon
357
Trimble
TRMB
$13.8B
$10.6M 0.05%
+273,000
New +$9.82M
NDAQ icon
358
Nasdaq
NDAQ
$50.1B
$10.6M 0.05%
859,500
+326,700
+61% +$4.22M
ARUN
359
DELISTED
ARUBA NETWORKS, INC.
ARUN
$10.6M 0.05%
564,000
+344,000
+156% +$6.89M
MPC icon
360
Marathon Petroleum
MPC
$116B
$10.5M 0.05%
242,326
-254
-0.1% -$11.1K
NBIS
361
Nebius Group N.V.
NBIS
$56.9B
$10.3M 0.05%
342,535
+160,121
+88% +$5.91M
ROP icon
362
Roper Technologies
ROP
$38.2B
$10.3M 0.05%
77,421
+7,777
+11% +$1.06M
ITUB icon
363
Itaú Unibanco
ITUB
$91B
$10.3M 0.04%
1,901,530
-15,676
-0.8% -$74.8K
TFC icon
364
Truist Financial
TFC
$61.9B
$10.3M 0.04%
255,800
-90,649
-26% -$3.47M
MEOH icon
365
Methanex
MEOH
$4.95B
$10.2M 0.04%
159,700
-31,900
-17% -$2.01M
LEA icon
366
Lear
LEA
$6.3B
$10.2M 0.04%
122,116
+33,821
+38% +$2.69M
ONIT
367
Onity Group
ONIT
$285M
$10.2M 0.04%
17,333
+800
+5% +$519K
BCE icon
368
BCE
BCE
$21.5B
$10.1M 0.04%
233,440
+5,631
+2% +$240K
WU icon
369
Western Union
WU
$2.15B
$10M 0.04%
612,538
+463,000
+310% +$7.54M
PTR
370
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$9.93M 0.04%
91,482
-27,049
-23% -$2.77M
VTR icon
371
Ventas
VTR
$45.3B
$9.92M 0.04%
143,359
+38,603
+37% +$2.68M
TGT icon
372
Target
TGT
$70.8B
$9.9M 0.04%
163,652
-39,681
-20% -$2.35M
EWG icon
373
iShares MSCI Germany ETF
EWG
$1.69B
$9.88M 0.04%
314,978
+481
+0.2% +$14.9K
TGNA
374
DELISTED
TEGNA Inc
TGNA
$9.8M 0.04%
678,600
+357,077
+111% +$5.31M
TROW icon
375
T. Rowe Price
TROW
$22.4B
$9.76M 0.04%
118,563
-4,496
-4% -$364K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.